Know Cancer

or
forgot password

Phase III of the AB Prep Safety and Efficacy in Colon Cleansing


Phase 3
12 Years
75 Years
Open (Enrolling)
Both
Colon Cancer

Thank you

Trial Information

Phase III of the AB Prep Safety and Efficacy in Colon Cleansing


The available colon cleansing preps have issues with patient's tolerance( Abdominal pain,
nausea, vomiting), and as recently noted by the FDA safety issues such a change in EKG,
blood electrolytes requiring 72 hours to correct, and most recently PO4 nephropathy.

The AB Prep is a 16 tablets prep that has excellent patient's tolerance efficacy, with no
change in blood electrolytes or EKG. ( PhaseI (20 patients) and Phase II (200 patients)

The protocol that was used is as follows:

(IND application # 75,704)

Protocol design for testing the safety and efficacy of the AB Prep:

The AB Prep is a combination of 2 Reglan tablets (10mg each), 6 Dulcolax tablets, and 8
K-Phos Neutral tablets. The combination is given in two steps, four hours apart; the day
before the colonoscopy.

As before, the objective of this clinical trial is to examine the AB Prep first and foremost
for safety, and second for efficacy of colon cleansing.

The proposed trial is for One-Arm Study of subjects undergoing elective and therapeutic
colonoscopy.

Phase III: 400 patients, The selection will be random, the age probably ranging from 12 to
75 years old.

The patients will have a Pre, and post procedural EKG, comprehensive (Sodium, Potassium,
Creatinine, BUN, Calcium, Magnesium, Phosphate, Glucose), and vital signs.

The patients with severe constipation (One bowel movement per week or more) will not be
included in the study. (In our experience, those people required two days prep to achieve
colon cleansing).

The SRSS statistical program will be used for data collection and analysis:

The end point of the study is colon cleansing, adequate enough to perform colonoscopy. The
colon cleansing will be graded as follow:

1. Poor colon prep, unable to proceed with colonoscopy.

2. Able to do colonoscopy with, the colon cleansing labeled as:

A- Excellent, Totally cleansed B- Good, adequately cleansed, with need for irrigation.

In addition to efficacy, we would like to check for patient's satisfaction and compliance,
(Most common complaints that the patients tend to voice with the present approved colon
preps).

Patient's satisfaction data will be collected before the procedure and will be graded as
follow:

1. Totally satisfied with the Prep, without any complaints

2. Satisfied, with the following complaints (Nausea, vomiting, abdominal pain/cramping)

3. Unsatisfied with the Prep (Reasons!!!)

Patient's compliance will be graded as follow:

1. Compliant

2. Non compliant(Reasons).

The prep instruction will be as follows REPARATION FOR COLONOSCOPY

FIVE DAYS before your procedure:

1. If you take COUMADIN or PLAVIX, we recommend that you stop these medications. You must
contact your primary care physician or cardiologist for specific instructions. You may
restart these medications again after the procedure unless otherwise instructed.

2. If you have DIABETES and take medication to control your blood sugar, contact your
primary care physician or diabetes doctor for instructions about how to take your
diabetes medication while preparing for this procedure.

3. Stop taking iron or multivitamins that contain iron.

4. Avoid the use of aspirin and aspirin-like medications such as ibuprofen, Advil and
Aleve. These medicines may increase your risk of bleeding after polyp removal.

5. Start a low-roughage diet and do not eat corn or raw vegetables. You may re-start your
usual diet after the procedure.

TWO DAYS before the procedure:

1. Take 2 tablets of Dulcolax at 8:00 PM.

ONE DAY before the procedure:

1. Begin a clear liquid diet at breakfast and continue this diet until 4 hours before your
procedure. A clear liquid diet includes: water, tea, black coffee, clear broth, apple
juice, white grape juice, Gatorade, soda, Jell-O. Do not eat or drink anything red,
including red Jell-O. Do not drink milk. Do not use sugar-free drinks. All patients,
including those with DIABETES, should be sure they get enough sugar during this time.

2. At 8:00 AM, take One Reglan(10mg) tablet, 2 Dulcolax tablets, and 4 tablets of K-PHOS
NEUTRAL. Drink three glasses of water/juice SLOWLY over 1 hour. The laxative effect
begins in about 2 hours. BE SURE TO DRINK AT LEAST 3 GLASSES OF WATER OR JUICE AFTER
TAKING EACH DOSE OF THE prep.( Each Glass =350cc)

3. At 12:00 Noon, Take 2 Dulcolax tablets and 4 tablets of K-PHOS NEUTRAL, along with 3
glasses of water/Juice.(Each glass =350cc).

ON THE DAY of your procedure:

1. Take all of your usual medicines and 1 tablet of Reglan (10mg). Do Not Take Coumadin,
Plavix, or Aspirin. If you take INSULIN, take 1/2 your usual dose.

2. If you have a medical condition requiring antibiotics before or after procedures, we
will determine whether they are needed for your colonoscopy.

3. STOP CLEAR LIQUIDS 4 HOURS BEFORE YOUR PROCEDURE (except for small amount of water with
medications). DO NOT EAT OR DRINK ANYTHING UNTIL AFTER YOUR PROCEDURE.

4. Wear loose-fitting, comfortable clothes.

5. Read the consent form. You will be asked to sign the form before your procedure.

Please bring these things WITH YOU to your procedure:

1. A list of all of your medications, including the doses

2. Your identification or insurance card

3. The name and phone number of your escort.

AFTER your procedure:

1. You will be monitored in the Endoscopy Unit recovery area for 20-30 minutes.

2. You may have some abdominal bloating after the procedure. It should resolve within an
hour.

4. You may eat your normal diet after the procedure.

5. You may return to work the day after the procedure.

HELPFUL HINTS FOR PATIENTS UNDERGOING COLONOSCOPY

1.Use moist wipes (baby wipes) instead of toilet paper.


Inclusion Criteria:



- Any eligible patient for colonoscopy

Exclusion Criteria:

- Patients with renal failure

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

TOTAL COLON CLEANSING, TO BE ABLE TO PERFORM COLONOSCOPY

Outcome Time Frame:

IMMEDIATE, DURING THE COLONOSCOPY

Safety Issue:

Yes

Principal Investigator

SEMAAN M ABBOUD, MD

Investigator Role:

Principal Investigator

Authority:

United States: Food and Drug Administration

Study ID:

ABBPREP1

NCT ID:

NCT00817934

Start Date:

January 2009

Completion Date:

January 2010

Related Keywords:

  • Colon Cancer
  • Efficacy
  • patient's tolerance
  • patient's safety
  • Colonic Neoplasms

Name

Location

Cedar Tree Surgical CenterMillsboro, Delaware  19966